| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 14121-55-2 | 6-Quinoxalinecarboxylicacid, 1,2,3,4-tetrahydro-2,3-dioxo-; 6-Quinoxalinecarboxylicacid, 2,3-dihydroxy- (8CI); 2,3-Dihydroxy-6-quinoxalinecarboxylic acid; 2,3-Dioxo-1,2,3,4-tetrahydro-quinoxaline-6-carboxylicacid; NSC 211121 |  | C9H6N2O4 | 詳情 | 供應(yīng)商 | |
| 117007-39-3 | 6H-Indolo[2,3-b]quinoxaline-6-aceticacid, 2-[1-(2-bromo-4-nitrophenyl)ethylidene]hydrazide; 6H-Indolo[2,3-b]quinoxaline-6-aceticacid, [1-(2-bromo-4-nitrophenyl)ethylidene]hydrazide (9CI) |  | C24H17BrN6O3 | 詳情 | 供應(yīng)商 | |
| 30990-64-8 | 6H-3l4-[1,2,5]Oxaselenazolo[4,3,2-hi][2,1,3]benzoxaselenazole,7,8-dihydro-7,7-dimethyl- (9CI); 6H-[1,2,5]Oxaselenazolo[4,3,2-hi][2,1,3]benzoxaselenazole-3-SeIV,7,8-dihydro-7,7-dimethyl- (8CI); NSC 328587 |  | C8H12N2O2Se | 詳情 | 供應(yīng)商 | |
| 6413-22-5 | 6,10-Dioxaspiro[4.5]decane,7,9-dimethyl-; NSC 6560 |  | C10H18O2 | 詳情 | 供應(yīng)商 | |
| 107373-23-9 | 6,8,11,14-Eicosatetraenoicacid, 5,20-dihydroxy-, (5S,6E,8Z,11Z,14Z)-; 6,8,11,14-Eicosatetraenoicacid, 5,20-dihydroxy-, [S-(E,Z,Z,Z)]- |  | C20H32O4 | 詳情 | 供應(yīng)商 | |
| 112915-00-1 | 6H-Purin-6-one,2-amino-1,9-dihydro-9-[(1R,3S)-3-(hydroxymethyl)cyclopentyl]-, rel-; 6H-Purin-6-one,2-amino-1,9-dihydro-9-[3-(hydroxymethyl)cyclopentyl]-, cis- (9CI); 6H-Purin-6-one, 2-amino-1,9-dihydro-9-[3-(hydroxymethyl)cyclopentyl]-, cis-(?à)-; NSC 615813 |  | C11H15N5O2 | 詳情 | 供應(yīng)商 | |
| 91516-84-6 | 6H-Purin-6-one,2-amino-1,9-dihydro-9-[[2-(phosphonooxy)-1-[(phosphonooxy)methyl]ethoxy]methyl]-; 9-(1,3-dihydroxy-2-propoxymethyl)-guanine-bis(monophosphate) |  | C9H15N5O10P2 | 詳情 | 供應(yīng)商 | |
| 6836-39-1 | 6-Tetradecanol; NSC 158518 |  | C14H30O | 詳情 | 供應(yīng)商 | |
| 242-50-2 | 6H-Dibenzo[b,h]carbazole |  | C20H13N | 詳情 | 供應(yīng)商 | |
| 60755-80-8 | 6H-Benzofuro[3a,3,2-ef][2]benzazepine-3,6-diol,4a,5,9,10,11,12-hexahydro-11-methyl-, (4aS,6R,8aS)-; Galanthamine,O-demethyl-; 6H-Benzofuro[3a,3,2-ef][2]benzazepine-3,6-diol,4a,5,9,10,11,12-hexahydro-11-methyl-, [4aS-(4aa,6b,8aR*)]-; O-Demethylgalanthamine; Sanguinine |  | C16H19NO3 | 詳情 | 供應(yīng)商 | |
| 16101-08-9 | 6H-Pyrido[4,3-b]carbazole,9-methoxy-1,5-dimethyl-; 10-Methoxyolivacine; 9-Methoxyolivacine |  | C18H16N2O | 詳情 | 供應(yīng)商 | |
| 56689-43-1 | 6H-Dibenzo[b,d]pyran-1,9-diol,3-(1,1-dimethylheptyl)-6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-; Canbisol; Nabidrox |  | C24H38O3 | 詳情 | 供應(yīng)商 | |
| 113106-55-1 | 6H-Cyclohepta[b]quinoline,11-[4-(4-chlorophenyl)-1-piperazinyl]-7,8,9,10-tetrahydro- |  | C24H26ClN3 | 詳情 | 供應(yīng)商 | |
| 152490-59-0 | 6H-Benzofuro[3,2-c][1]benzopyran-8-ol,9-(cyclohexylmethoxy)-6a,11a-dihydro-3-methoxy-, cis- (9CI) |  | C23H26O5 | 詳情 | 供應(yīng)商 | |
| 71774-08-8 | 6,8,11,14-Eicosatetraenoicacid, 5-hydroperoxy-, (5S,6E,8Z,11Z,14Z)-; 6,8,11,14-Eicosatetraenoicacid, 5-hydroperoxy-, [S-(E,Z,Z,Z)]-; 5(S)-HPETE; 5(S)-Hydroperoxy-6-trans-8,11,14-cis-eicosatetraenoicacid; 5(S)-Hydroperoxy-6trans,8cis,11cis,14cis-eicosatetraenoic acid; 5(S)-Hydroperoxyeicosa-6E,8Z,11Z,14Z-tetraenoic acid; 5(S)-Hydroperoxyeicosatetraenoic acid; 5(S)-Hydroxyperoxy-6-trans-8,11,14-cis-eicosatetraenoic acid |  | C20H32O4 | 詳情 | 供應(yīng)商 | |
| 69548-65-8 | 6H-Pyrido[2,3-b][1,4]benzodiazepin-6-one,5,11-dihydro-11-[1-oxo-4-(1-pyrrolidinyl)butyl]- |  | C20H22N4O2 | 詳情 | 供應(yīng)商 | |
| 6466-15-5 | 6H-Purin-6-one,1,2,3,9-tetrahydro-1,3-dimethyl-8-[(3-pyridinylmethyl)thio]-2-thioxo-; Theophylline,8-[(3-pyridylmethyl)thio]-2-thio- (7CI,8CI); NSC 99664 |  | C13H13N5OS2 | 詳情 | 供應(yīng)商 | |
| 116989-67-4 | 6H-Indolo[2,3-b]quinoxaline-6-aceticacid, 9-chloro-, 2-[[(4-bromophenyl)amino]thioxomethyl]hydrazide |  | C23H16BrClN6OS | 詳情 | 供應(yīng)商 | |
| 97744-84-8 | 6H-1,3-Dioxolo[4,5-g][1]benzopyran-6-one,8-(bromomethyl)-; 4-(Bromomethyl)-6,7-(methylenedioxy)coumarin |  | C11H7BrO4 | 詳情 | 供應(yīng)商 | |
| 94088-14-9 | 6-Nonen-1-yn-4-ol, (Z)-(9CI); (Z)-non-6-en-1-yn-4-ol |  | C9H14O | 詳情 | 供應(yīng)商 | |